Supply Issues Juiceworks Ltd Sugar Free Jelly Products ALU049 and ALU050 (ICN 2568)

• The supply issue with Sugar Free Jelly products from Juice Works Ltd is continuing.
• Two product codes remain affected in total:
  • ALU049 – Jelly Sugar-Free Orange
  • ALU050 – Jelly Sugar-Free Strawberry.
• ALU049 and ALU050 remain subject to Protect Demand Management.
• Both products are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• There are currently no identified alternative products available to order through our online catalogue.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and for a full list of product codes subject to Protect Demand Management.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is now anticipated to be resolved by 16 August 2024.

• The supply issue with Sugar Free Jelly products from Juice Works Ltd is continuing.
• Due to this ongoing supply issue the affected products are now being threshold managed as they are subject to Protect Demand Management:
  • ALU049 – Jelly Sugar-Free Orange
  • ALU050 – Jelly Sugar-Free Strawberry.
• The products are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Unfortunately, there are no identified alternative products available to order through our online catalogue.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and for a full list of product codes subject to Protect Demand Management.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is still anticipated to be resolved by 31 July 2024.

• The supply issue with Sugar Free Jelly products from Juice Works Ltd has improved.
• The affected products are now available to order through our online catalogue but are subject to intermittent supply:
  • ALU049 – Jelly Sugar-Free Orange
  • ALU050 – Jelly Sugar-Free Strawberry.
• Unfortunately, there are no identified alternatives available through our online catalogue.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is still anticipated to be resolved by 31 July 2024.

Change:

• The supplier Juiceworks Ltd has informed us of a supply issue with its Sugar Free Jelly products.
• The two product codes affected are:
  • ALU049 – Jelly Sugar-Free Orange
  • ALU050 – Jelly Sugar-Free Strawberry.
• The supply issue is due to manufacturing issues.

Impact:          

• The affected codes are currently suspended and unavailable to order.
• Unfortunately, there are no identified alternatives available through our online catalogue.
• We are currently sourcing further alternatives and will update the product listing as soon as possible.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes.
• The supply issue is anticipated to be resolved by 31 July 2024.

 Next Steps:               

• Customers are advised to log into our website to view the product listing for further information on the affected product codes.
• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

 Please note that due to the clinical nature of these alternative products, we advise you to consult your clinical experts to ensure suitability for your organisations use of these products.